Cargando…
The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations
With the current crisis related to the emergence of carbapenem-resistant Gram-negative bacteria (CR-GNB), classical treatment approaches with so-called “old-fashion antibiotics” are generally unsatisfactory. Newly approved β-lactam/β-lactamase inhibitors (BLBLIs) should be considered as the first-li...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868358/ https://www.ncbi.nlm.nih.gov/pubmed/35203879 http://dx.doi.org/10.3390/antibiotics11020277 |